Bill > S05352

This bill amends the New York State education law to require prescribers (such as doctors) and pharmacists to notify patients when they are prescribed or dispensed a different generic drug product than what the patient has previously received. Specifically, the notification must be provided both orally and in writing, ensuring that patients are fully informed about any changes to their medication. Generic drug products are medications that are chemically equivalent to brand-name drugs but are typically sold at a lower cost. The goal of this legislation appears to be increasing patient awareness and transparency about their medications, allowing patients to understand when their prescription has been substituted with a different generic version. The bill will go into effect 90 days after it becomes law, giving healthcare providers time to implement the new notification requirements.

Education

https://www.nysenate.gov/legislation/bills/2025/S5352